Altretamine | CAS 645-05-6 | Alkylating Antineoplastic Agent for Laboratory Research

Description Contents hide 1 Product Description 2 Product Specifications 3 Mechanism of Action 3.1 1. DNA Alkylation and Crosslink Formation 3.2 2. Induction of Apoptosis 3.3 3. Cell Cycle Disruption 3.4 4. Synergistic Experimental Applications 3.5 5. Model Compound for Mechanistic Studies 4 Side Effects 5 Keywords 6 Shipping Guarantee 7 Trade Assurance 8 Payment Support 9 Disclaimer Product DescriptionAltretamine, also known as hexamethylmelamine, is a lipophilic triazine derivative that functions as an alkylating cytotoxic agent in experimental oncology research. Its mechanism involves the formation of DNA crosslinks, resulting in replication inhibition, transcriptional interference, and subsequent tumor cell apoptosis.This compound is widely used in laboratory studies to explore chemotherapeutic efficacy, DNA damage response pathways, and drug resistance mechanisms. Researchers employ Altretamine to investigate the sensitivity of various cancer cell lines, including ovarian carcinoma and melanoma models, to alkylating cytotoxic stress.In preclinical models, Altretamine administration leads to the induction of DNA adducts and interstrand crosslinks, which disrupt the normal DNA replication process. Its alkylation preferentially occurs at guanine and adenine bases, contributing to the cytotoxicity observed in proliferating tumor cells. The study of Altretamine allows researchers to dissect pathways of DNA repair, apoptotic signaling, and cell cycle checkpoint activation.Due to its lipophilic nature, Altretamine readily penetrates cellular membranes, ensuring intracellular access to nuclear DNA. In laboratory conditions, it has been demonstrated to induce cell cycle arrest primarily at the G2/M phase, providing a useful tool to study cell division regulation and chemotherapeutic intervention strategies.Altretamine also serves as a model compound for examining combinatorial chemotherapy regimens, often studied in conjunction with platinum-based agents, topoisomerase inhibitors, or microtubule-targeting drugs to evaluate synergistic cytotoxicity in experimental settings.Product SpecificationsItemDetailsProduct NameAltretamineCAS Number645-05-6SynonymsHexamethylmelamine, HMMMolecular FormulaC_12H_27N_3Molecular Weight237.37 g/molPurity≥99%AppearanceWhite to off-white crystalline powderSolubilitySoluble in DMSO and ethanolStorage Temperature2–8 °C, protected from lightCategoryAlkylating antineoplastic agentApplicationsDNA crosslinking studies, cytotoxicity assays, chemoresistance research, preclinical cancer modelingFormulationLyophilized powder or solution for laboratory experimentsStabilityStable under recommended storage conditionsShelf Life24 monthsSupplier TypeLaboratory research chemical supplierIntended UseFor laboratory and preclinical research onlyMechanism of ActionAltretamine acts as an alkylating agent that induces DNA damage in proliferating tumor cells. Its primary mechanism of action involves covalent binding to nucleophilic sites on DNA, leading to interstrand and intrastrand crosslinks.1. DNA Alkylation and Crosslink FormationAltretamine forms electrophilic intermediates that alkylate guanine and adenine residues in DNA. The resultant crosslinks impede DNA replication and transcription, leading to replication fork stalling and cell cycle arrest. This cytotoxic mechanism is central to its antineoplastic activity in experimental models.2. Induction of ApoptosisDNA crosslinking triggers DNA damage response pathways, including activation of ATM/ATR kinases and p53-mediated apoptotic signaling. The accumulation of DNA lesions leads to programmed cell death in sensitive tumor cell populations.3. Cell Cycle DisruptionAltretamine treatment commonly results in G2/M cell cycle arrest. This arrest allows the accumulation of DNA damage and provides a platform for studying checkpoint control and repair mechanisms in laboratory models.4. Synergistic Experimental ApplicationsIn preclinical research, Altretamine is often studied in combination with platinum-based compounds or other chemotherapeutics to evaluate synergistic effects, potential enhancement of cytotoxicity, and overcoming chemoresistance mechanisms.5. Model Compound for Mechanistic StudiesDue to its well-characterized DNA crosslinking activity, Altretamine serves as a valuable tool for studying DNA repair pathways, including nucleotide excision repair, homologous recombination, and mismatch repair, in both in vitro and in vivo research models.Side EffectsAltretamine is strictly for laboratory and preclinical research and not intended for human use. Potential experimental considerations include:Cytotoxicity to cultured cells requiring precise dose titration;Potential instability in solution if not stored appropriately;Lipophilic properties necessitate careful solvent selection;Handling requires standard laboratory safety protocols, including PPE and fume hood usage.KeywordsAltretamine, Hexamethylmelamine, HMM, alkylating antineoplastic agent, DNA crosslinking, cytotoxicity research, preclinical cancer research, chemoresistance studies, laboratory research chemical, high-purity antineoplastic agentShipping GuaranteeAll shipments are handled using validated cold-chain or controlled-environment logistics to preserve compound integrity. Packages are sealed in moisture-proof and light-protective containers and shipped via express international couriers with tracking and insurance.Trade AssuranceWe guarantee product authenticity, verified ≥99% purity, and compliance with analytical standards such as HPLC and NMR. Each batch is accompanied by a Certificate of Analysis (CoA). Our trade assurance policy ensures replacement or refund for any deviation from listed specifications.Payment SupportFlexible and secure global payment options are available, including PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). Transactions are protected by industry-standard encryption.DisclaimerAll products are intended for laboratory and preclinical research use only. They are not drugs, medical devices, or diagnostics, and should not be administered to humans or animals. Researchers must follow institutional biosafety guidelines. The information provided is for scientific reference and does not imply therapeutic efficacy or regulatory approval.